QSI Strangle Strategy
QSI (Quantum-Si incorporated), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.
QSI (Quantum-Si incorporated) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $182.6M, a beta of 3.16 versus the broader market, a 52-week range of 0.691-3.1, average daily share volume of 4.5M, a public-listing history dating back to 2020, approximately 149 full-time employees. These structural characteristics shape how QSI stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 3.16 indicates QSI has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a strangle on QSI?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current QSI snapshot
As of May 15, 2026, spot at $0.89, ATM IV 92.96%, IV rank 17.19%, expected move 26.65%. The strangle on QSI below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.
Why this strangle structure on QSI specifically: QSI IV at 92.96% is on the cheap side of its 1-year range, which favors premium-buying structures like a QSI strangle, with a market-implied 1-standard-deviation move of approximately 26.65% (roughly $0.24 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated QSI expiries trade a higher absolute premium for lower per-day decay. Position sizing on QSI should anchor to the underlying notional of $0.89 per share and to the trader's directional view on QSI stock.
QSI strangle setup
The QSI strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With QSI near $0.89, the first option leg uses a $0.93 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed QSI chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 QSI shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $0.93 | N/A |
| Buy 1 | Put | $0.85 | N/A |
QSI strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
QSI strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on QSI. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on QSI
Strangles on QSI are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the QSI chain.
QSI thesis for this strangle
The market-implied 1-standard-deviation range for QSI extends from approximately $0.65 on the downside to $1.13 on the upside. A QSI long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current QSI IV rank near 17.19% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on QSI at 92.96%. As a Healthcare name, QSI options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to QSI-specific events.
QSI strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. QSI positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move QSI alongside the broader basket even when QSI-specific fundamentals are unchanged. Always rebuild the position from current QSI chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on QSI?
- A strangle on QSI is the strangle strategy applied to QSI (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With QSI stock trading near $0.89, the strikes shown on this page are snapped to the nearest listed QSI chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are QSI strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the QSI strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 92.96%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a QSI strangle?
- The breakeven for the QSI strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current QSI market-implied 1-standard-deviation expected move is approximately 26.65%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on QSI?
- Strangles on QSI are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the QSI chain.
- How does current QSI implied volatility affect this strangle?
- QSI ATM IV is at 92.96% with IV rank near 17.19%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.